Have Merck beaten us to the punch?, page-38

Merck did a Joint Venture with Ridgeback Biotherapeutics to release the Covid-19 treatment molnupiravir.

Yes, they have beaten BIT to the punch so far.
As far as I know, it is also a small molecule drug.

There can be little excuses from MM on the commercial aspects of the business such as dealmaking .


But the fight is far from over with covid19.
Covid19 is going to be around for a while.
The opportunity is still present.

MM would do well to analyse what Ridgeback Biotherapeutics did right to secure a deal with Big Pharma!!!
I note...
molnupiravir is not 100% effective...and it doesn't have to be!!!

ie.
Did you know they tested their candidate against covid19 using ferrets?
There was a reason for that also.
Some of the testing was sponsored by the US government also for this drug!

BIT need to do a JV deal with the remaining Big Pharma with their best covid19 candidates or a deal with the governments.

They need to partner with Big Pharma or Government to take advantage of the fastracking.
There is a huge unmet need still.

Fortunately for BIT, there is the covid19 candidates and the BIT225 for HIV!
With the appropriate deal, BIT would easily become a multibagger.

The focus needs to be solely on the dealmaking with Big Pharma.

GLA BIT holders